back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-01-04 17:11 Tx date 2022-12-30 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+8,185 vol |
563,891 | |
| Filed 2022-10-05 17:48 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-500,000 vol |
0 | |
| Filed 2022-10-05 17:46 Tx date 2022-09-30 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
$783,545
+555,706 vol $1.41 each |
555,706 | |
| Filed 2022-10-05 17:43 Tx date 2018-08-16 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-14 18:38 Tx date 2021-12-09 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$397,500
+150,000 vol $2.65 each |
500,000 | |
| Filed 2019-10-16 14:33 Tx date 2019-10-15 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
10 - Acquisition or disposition in the public market
|
$27,200
+10,000 vol $2.72 each |
110,000 | |
| Filed 2019-01-04 Tx date 2019-01-03 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$645,000
+150,000 vol $4.30 each |
350,000 | |
| Filed 2018-12-21 Tx date 2018-08-16 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
200,000 | ||
| Filed 2018-12-21 Tx date 2018-08-16 |
$CRDL
Cardiol Therapeutics Inc. |
Waddick, Christopher James
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares (Class A)
00 - Opening Balance-Initial SEDI Report
|
100,000 |